Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial. (Q33899917)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q52150739)
(Q115608591)
(P304) 1860-1867
(P407) (Q1860)
(P433) 23
(P478) 74
(P577) Tuesday, June 1, 2010
(P921) (Q42824440)
(Q8277)
(Q412323)
(P1433) (Q1161692)
(P1476) "Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial" (language: en)
(P2093) R T Naismith
L Piccio
J A Lyons
J Lauber
N T Tutlam
B J Parks
S K Song
(P2860) (Q34052870)
(Q28268626)
(Q36724438)
(Q35585366)
(Q36519664)
(Q22252938)
(Q34327451)
(Q34514278)
(Q34100103)
(Q29614990)
(Q52040025)
(Q42802801)
(Q36349536)
(Q40141450)
(Q39450637)
(Q45119459)
(Q45214987)
(Q47395264)
(Q53482190)
(Q48361641)
(Q47685354)
(Q36792204)
(Q48215974)
(Q77404703)
(Q73493149)
(Q77327909)
(Q93737208)
(Q70180407)
other details
description scientific article

External Links